What is King Pharmaceuticals's international — year 6?

King Pharmaceuticals (KG) reported international — year 6 of 0.7% in Q4 2025.

What does international — year 6 mean?

Captures the financial performance and operational results of the International insurance product line during the sixth year of the reporting cycle. This data point allows for the analysis of year-over-year changes in risk appetite and premium volume within international markets. It helps stakeholders evaluate the segment's contribution to overall corporate profitability.

King Pharmaceuticals KG International — Year 6

Other product segments

General Liability

10.8%—

Commercial Auto Liability

8.6%—

European Hospital Liability

8.5%—

All other lines

-0.9%—

Similar metrics at other companies

CNAInternational — Year 10

1.3%—

CNAInternational — Year 7

5.6%—

CNAInternational — Year 8

2.6%—

CNAInternational — Year 9

2.8%—

CNAInternational — Year 6

6.5%—

HGInternational - Specialty — 6

4%-2.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — year 6.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's international — year 6?: King Pharmaceuticals (KG) reported international — year 6 of 0.7% in Q4 2025.
What does international — year 6 mean?: Captures the financial performance and operational results of the International insurance product line during the sixth year of the reporting cycle. This data point allows for the analysis of year-over-year changes in risk appetite and premium volume within international markets. It helps stakeholders evaluate the segment's contribution to overall corporate profitability.